Skin testing and desensitization outcomes among platinum-sensitive oncology patients

Ann Allergy Asthma Immunol. 2018 Apr;120(4):437-439. doi: 10.1016/j.anai.2018.01.008.

Authors

Stephanie L Mawhirt¹, Luz S Fonacier², Rose Calixte³, Mark Davis-Lorton², Marcella R Aquino²

Affiliations

¹ Department of Rheumatology, Allergy, and Immunology, NYU Winthrop Hospital, Mineola, New York. Electronic address: smawhirt@nyuwinthrop.org.
² Department of Rheumatology, Allergy, and Immunology, NYU Winthrop Hospital, Mineola, New York.
³ Department of Biostatistics, NYU Winthrop Hospital, Mineola, New York.

PMID: 29625667
DOI: 10.1016/j.anai.2018.01.008

No abstract available

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Carboplatin / adverse effects*
Desensitization, Immunologic* / adverse effects
Drug Hypersensitivity / diagnosis*
Drug Hypersensitivity / therapy*
Female
Humans
Male
Middle Aged
Neoplasms / drug therapy
Oxaliplatin / adverse effects*
Skin Tests

Substances

Antineoplastic Agents
Oxaliplatin
Carboplatin